RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
Liver Fibrosis - Pipeline Review, Q2 2011
Apr 2011 - 45 pages - $500
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 52 pages - $1,000
Liver Fibrosis - Pipeline Review, H2 2011
Aug 2011 - 60 pages - $500
Cystic Fibrosis Therapy Area Pipeline Report
Nov 2010 - 176 pages - $1,495
Pulmonary Fibrosis Therapy Area Pipeline Report
Nov 2010 - 115 pages - $1,495
Cystic Fibrosis - Pipeline Review, H2 2011
Sep 2011 - 174 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Geographic location
Asia del
Laos del

Browse By

Industry sector
Bioinformatics
Combinatorial biology
Combinatorial chemistry
Drug research platforms
Genomics
High throughput screening
Proteomics

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us